🔎 Trials Near Me

Home › Type 2 Diabetes › District of Columbia

Type 2 Diabetes clinical trials in District of Columbia

7 studies for Type 2 Diabetes are looking for participants at sites in District of Columbia.

Cities in District of Columbia

Plant-Based Online Weight Loss Through Education and Resources Program and Study

  • Physicians Committee for Responsible Medicine, Washington D.C.
Recruiting
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07095543

Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study

  • Children's National Hospital (CNH), Washington D.C.
RecruitingObservational studyHealthy volunteers welcome
Ages 12 to 25 · All sexes · Updated Sep 17, 2026 · NCT06730113

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Emerson Clinical Research Institute, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07351058

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

  • Emerson Clinical Research Institute, Washington D.C.
  • Children's National Medical Center, Washington D.C.
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Aug 7, 2026 · NCT06739122

RESET System Pivotal Trial (Rev F)

  • MedStar Health Research Institute, Washington D.C.
Recruiting
Ages 22 to 65 · All sexes · Updated Jul 18, 2024 · NCT04101669

Diabetes Reversal Online Program and Study (DROP Study)

  • Physician Committee for Responsible Medicine, Washington D.C.
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Apr 18, 2024 · NCT05572502

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.